SARAH MORROW: Open Payments
NPI 1871155572 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 24 payments from 9 companies in 2025. Trend: 2023 $904 · 2024 $535 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 8 | $288 |
| Dexcom, Inc. | 1 | $154 |
| Gilead Sciences, Inc. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| PFIZER INC. | 3 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| CVRx, Inc. | 1 | $12 |
Products named: SYMPLICITY G3, DEXCOM G7 GSS (161), ELIQUIS, LEQVIO, ONPATTRO, Wegovy, MICRA, VYNDAQEL.
Industry payments across TX — which companies pay providers there.
